Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GDF-15 for Prognostication of Cardiovascular and Cancer Morbidity and Mortality in Men
Lars Wallentin, Björn Zethelius, Lars Berglund, et al.
PLoS ONE (2013) Vol. 8, Iss. 12, pp. e78797-e78797
Open Access | Times Cited: 115

Showing 26-50 of 115 citing articles:

Discovery of New Risk Markers for Ischemic Stroke Using a Novel Targeted Proteomics Chip
Lars Lind, Agneta Siegbahn, Bertil Lindahl, et al.
Stroke (2015) Vol. 46, Iss. 12, pp. 3340-3347
Open Access | Times Cited: 82
Identification of novel biomarkers for doxorubicin-induced toxicity in human cardiomyocytes derived from pluripotent stem cells
Gustav Holmgren, Jane Synnergren, Yalda Bogestål, et al.
Toxicology (2014) Vol. 328, pp. 102-111
Open Access | Times Cited: 76
GDF-15 and TRAIL-R2 are powerful predictors of long-term mortality in patients with acute myocardial infarction
Emma Skau, Egil Henriksen, Philippe Wagner, et al.
European Journal of Preventive Cardiology (2017) Vol. 24, Iss. 15, pp. 1576-1583
Closed Access | Times Cited: 70
Molecular biomarkers in cardiac hypertrophy
Liu Zhu, Chao Li, Qiang Liu, et al.
Journal of Cellular and Molecular Medicine (2019) Vol. 23, Iss. 3, pp. 1671-1677
Open Access | Times Cited: 69
Associations of Circulating Growth Differentiation Factor-15 and ST2 Concentrations With Subclinical Vascular Brain Injury and Incident Stroke
Charlotte Andersson, Sarah R. Preis, Alexa S. Beiser, et al.
Stroke (2015) Vol. 46, Iss. 9, pp. 2568-2575
Open Access | Times Cited: 67
Galectin-3: A Potential Prognostic and Diagnostic Marker for Heart Disease and Detection of Early Stage Pathology
Akira Hara, Masayuki Niwa, Tomohiro Kanayama, et al.
Biomolecules (2020) Vol. 10, Iss. 9, pp. 1277-1277
Open Access | Times Cited: 66
Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes
Daniel Lindholm, Stefan James, Katja Gabrysch, et al.
JAMA Cardiology (2018) Vol. 3, Iss. 12, pp. 1160-1160
Open Access | Times Cited: 64
The power of proteomics to monitor senescence-associated secretory phenotypes and beyond: toward clinical applications
Nathan Basisty, Abhijit Kale, Sandip Kumar Patel, et al.
Expert Review of Proteomics (2020) Vol. 17, Iss. 4, pp. 297-308
Open Access | Times Cited: 53
Growth‐differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP‐SHOCK II‐trial
Georg Fuernau, Christian Poenisch, Ingo Eitel, et al.
European Journal of Heart Failure (2014) Vol. 16, Iss. 8, pp. 880-887
Closed Access | Times Cited: 59
Lipoprotein‐Associated Phospholipase A 2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease
Lars Wallentin, Claes Held, Paul W. Armstrong, et al.
Journal of the American Heart Association (2016) Vol. 5, Iss. 6
Open Access | Times Cited: 58
NT-proBNP is a powerful predictor for incident atrial fibrillation — Validation of a multimarker approach
Emma Svennberg, Bertil Lindahl, Lars Berglund, et al.
International Journal of Cardiology (2016) Vol. 223, pp. 74-81
Closed Access | Times Cited: 52
Cardiovascular Biomarkers in Chronic Kidney Disease: State of Current Research and Clinical Applicability
Luis D’Marco, Antonio Bellasi, Paolo Raggi
Disease Markers (2015) Vol. 2015, pp. 1-16
Open Access | Times Cited: 51
Growth differentiation factor-15, a novel systemic biomarker of oxidative stress, inflammation, and cellular aging: Potential role in cardiovascular diseases
Angelo Michele de Candia, Diane Xavier de Ávila, Gustavo Rodolfo Moreira, et al.
American Heart Journal Plus Cardiology Research and Practice (2021) Vol. 9, pp. 100046-100046
Open Access | Times Cited: 34
Association of GDF15 With Inflammation and Physical Function During Aging and Recovery After Acute Hospitalization: A Longitudinal Study of Older Patients and Age-Matched Controls
Juliette Tavenier, Line Jee Hartmann Rasmussen, Aino Leegaard Andersen, et al.
The Journals of Gerontology Series A (2021) Vol. 76, Iss. 6, pp. 964-974
Open Access | Times Cited: 33
Inflammageing and Cardiovascular System: Focus on Cardiokines and Cardiac-Specific Biomarkers
Marco Alfonso Perrone, Alberto Aimo, Sergio Bernardini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 844-844
Open Access | Times Cited: 15
Growth-differentiation factor 15 and risk of major bleeding in atrial fibrillation: Insights from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial
Ziad Hijazi, Jonas Oldgren, Ulrika Andersson, et al.
American Heart Journal (2017) Vol. 190, pp. 94-103
Closed Access | Times Cited: 46
Epidemiology of cardiovascular disease: recent novel outlooks on risk factors and clinical approaches
Teemu Niiranen, Ramachandran S. Vasan
Expert Review of Cardiovascular Therapy (2016) Vol. 14, Iss. 7, pp. 855-869
Open Access | Times Cited: 43
Macrophage inhibitory cytokine-1/growth differentiation factor 15 as a marker of cognitive ageing and dementia
Jiyang Jiang, Wei Wen, Perminder S. Sachdev
Current Opinion in Psychiatry (2016) Vol. 29, Iss. 2, pp. 181-186
Closed Access | Times Cited: 40
An Automated Assay for Growth Differentiation Factor 15
Kai C. Wollert, Tibor Kempf, Evangelos Giannitsis, et al.
The Journal of Applied Laboratory Medicine (2017) Vol. 1, Iss. 5, pp. 510-521
Open Access | Times Cited: 40
Growth differentiation factor‐15 and the risk of cardiovascular diseases and all‐cause mortality: A meta‐analysis of prospective studies
Shanhui Xie, Liping Lu, Liwei Liu
Clinical Cardiology (2019) Vol. 42, Iss. 5, pp. 513-523
Open Access | Times Cited: 37
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers
Michela Chianca, Giorgia Panichella, Iacopo Fabiani, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 20
Mechanisms and pharmacotherapy of cancer cachexia‐associated anorexia
Ryosuke Sato, Guilherme Wesley Peixoto da Fonseca, Willian das Neves, et al.
Pharmacology Research & Perspectives (2025) Vol. 13, Iss. 1
Open Access
GDF-15 Is Associated with Cancer Incidence in Patients with Type 2 Diabetes
Noémi Pávó, Raphael Wurm, Stephanie Neuhold, et al.
Clinical Chemistry (2016) Vol. 62, Iss. 12, pp. 1612-1620
Open Access | Times Cited: 32
Growth Differentiation Factor-15 (GDF-15) Is Associated With Mortality in Ischemic Stroke Patients Treated With Acute Revascularization Therapy
Céline Brenière, Alexandre Méloux, Martin Pédard, et al.
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 30
Ageing-related markers and risks of cancer and cardiovascular disease: a prospective study in the EPIC-Heidelberg cohort
Bernard Srour, Rudolf Kaaks, Theron Johnson, et al.
European Journal of Epidemiology (2021) Vol. 37, Iss. 1, pp. 49-65
Open Access | Times Cited: 26

Scroll to top